First-Line Maintenance Therapy Patterns in BRCA Wild-Type, HRD-Negative or Biomarker-Unknown Advanced Epithelial Ovarian Cancer: A Five-Country European Real-World Study by APLUSA.
Simple Summary: Many women with advanced epithelial ovarian cancer do not have a biomarker to guide treatment decisions after initial chemotherapy. In this situation, doctors may choose different post-chemotherapy strategies depending on patient factors, local practice and national access to medicin...
| Publicado en: | Cancers Vol. 18; no. 16; pp. 2682 - 2695 |
|---|---|
| Autores principales: | , , , , , |
| Formato: | research tables/charts Journal Article |
| Publicado: |
MDPI
Aug2026
|
| Acceso en línea: | Ver este registro en EBSCOhost |